#161166

DLD-1/EGFP_ACE2

Cat. #161166

DLD-1/EGFP_ACE2

Cat. #: 161166

Organism: Human

Tissue: Colon

Disease: Cancer

Model: Transgenic

£575.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: T.R. Santhosh Kumar

Institute: Rajiv Gandhi Centre for Biotechnology

Tool Details
Handling
References

Tool Details

*FOR RESEARCH USE ONLY

  • Name: DLD-1/EGFP_ACE2
  • Cancer: Digestive/Gastrointestinal cancer
  • Cancers detailed: Colorectal adenocarcinoma
  • Research fields: Cancer;Disease (not cancer);Metabolism
  • Parental cell: DLD-1
  • Organism: Human
  • Gender: Male
  • Tissue: Colon
  • Disease: Cancer
  • Morphology: Epithelial
  • Growth properties: Adherent
  • Model: Transgenic
  • Crispr: No
  • Conditional: No
  • Description: SARS CoV2 permissive colon cancer cell line DLD1 validated for Spike protein binding and SARS CoV 2 pseudovirion assay

Handling

  • Growth medium: DMEM with 2mM L-Glutamine and 10% FBS (Heat inactivated), or RPMI 1640 with 2mM L-Glutamine and 10 Fetal Bovine serum.
  • Temperature: 37° C
  • Atmosphere: 5% CO2
  • Shipping conditions: Dry Ice
  • Storage medium: Growth medium + 10% DMSO
  • Storage conditions: Liquid Nitrogen
  • Initial handling information: Resuscitation: Rapidly thaw the frozen ampoule in a water bath at 37?‚°C for 1-2 minutes. Transfer the contents to a centrifuge tube and slowly add 5-10ml of pre-warmed growth media. Remove a sample for counting. Centrifuge at 100-150g for 2-3 minutes to pellet cells (a centrifugation step to remove the cryoprotectant is essential. Seed at the recommend density, e.g. greater than 10,000 cells per cm2.
  • Subculture routine: Subculture non-confluent cultures using trypsin/EDTA and 1:3 to 1:4, i.e. seeding at 1-4 x10,000 cells/cm?‹Â› .
  • Cultured in antibiotics: No

References

  • Unpublished